Sylvia Wulf named as Chief Executive Officer.
The biotechnology that makes its land-based AquAdvantage salmon grow faster through genetic engineering, has appointed the Senior Vice President of US Foods to run its operations, according to a press release.
Sylvia Wulf is currently in that position in the US food giant and has been President of the Manufacturing Division since 2011. Prior to US Foods, Ms. Wulf was a Tyson Foods executive and held high level positions at Sara Lee Corporation and Bunge Corp. She is currently on the Board of Directors and the Executive Committee of the National Fisheries Institute.
Her appointment has been planned to coincide with AquaBounty’s developing emphasis on the commercialisation of AquAdvantage salmon, as the majority of the required regulatory hurdles have been passed.
Dr. Ronald Stotish will remain as an Executive Director with responsibility for research and regulatory affairs. He said that he will continue to work closely with regulatory authorities involved in food and biotechnology in the United States, Canada, and other countries. He will also lead the continued technical development of new products and will work closely with Ms. Wulf in the planned expansion of the production organization both within North America and abroad.
Richard Clothier, Chairman of the Board of Directors said: “We are delighted to appoint Sylvia Wulf as the Chief Executive Officer of AquaBounty. Her wide and deep experience in the food industry in North America and its fish sector will be a vital asset in the production and marketing of AquAdvantage Salmon and in the development of additional products. This appointment greatly strengthens AquaBounty’s executive team at a crucial stage in the Company’s development, and the Board looks forward to a period of rapid growth under Sylvia’s leadership.
Sylvia Wulf said: “AquAdvantage Salmon is the type of innovation necessary to meet the rising consumer demand for a healthy source of protein, and salmon in particular, without placing further pressure on the sea and coastal environments. I look forward to working with Dr. Stotish and the team to successfully commercialize it both in North America and abroad.”
